NCT06892665

Brief Summary

During caesarean section, blood pressure variations especially a reduction in blood pressure (or hypotension) can bring harmful effects to mother and baby. This usually occurs after spinal anaesthesia is administered. Usually, the anaesthetist will treat hypotension as it occurs. However, a new medical device is now available to predict hypotension. It is called the Hypotension Prediction Index (HPI). This device allows the prediction of hypotension; hence, treatment can be given before it occurs. It has been widely utilised in major surgeries like abdominal tumour surgery and cardiac surgery worldwide and has shown a substantial reduction in hypotension. This study aims to determine whether the duration and severity of hypotension can be reduced when HPI is used in lower segment caesarean sections. The secondary objective of the study is to determine if the complication rate can be reduced in both mother and baby.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 9, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 25, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

May 23, 2025

Status Verified

May 1, 2025

Enrollment Period

10 months

First QC Date

March 9, 2025

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time-weighted average of Mean arterial pressure <65mmHg

    Calculated using a formula. TWA-MAP \< 65 mmHg = (the depth of hypotension\< MAP of 65 mmHg x time spent below a MAP of 65 mmHg (minutes))/(total duration of operation (minutes))

    From spinal anaesthesia to completion of surgery

Secondary Outcomes (7)

  • Incidence of nausea and vomiting,

    Perioperative up to 2 days

  • length of hospital stay

    Perioperative up to 2 weeks

  • maternal satisfaction

    Perioperative up to 2 weeks

  • incidence of surgical site infection

    Perioperative up to 2 weeks

  • Apgar score of feotal

    1 minute and 5 minutes after delivery

  • +2 more secondary outcomes

Study Arms (2)

Group 1: HPI Group

EXPERIMENTAL

There were 2 arm group, in Group 1the Acumen IQ cuff, with HPI and other haemodynamics parameters, is available to the anaesthetist to view and act upon.

Device: Hypotension prediction index

Group 2: NIBP Group

PLACEBO COMPARATOR

the attending anaesthetist will be blinded from the HPI parameters.

Device: Non invasive Blood Pressure Monitoring

Interventions

HPI and other haemodynamics parameters, is available to the anaesthetist to view and act upon

Also known as: HPI
Group 1: HPI Group

Anaesthetist will respond to hemodynamic variables using NIBP

Also known as: NIBP
Group 2: NIBP Group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParturients
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ≥ 37 weeks of gestation
  • Elective CS
  • Age between 18 - 40 years old
  • Singleton pregnancy
  • Planned for spinal anaesthesia

You may not qualify if:

  • American Society of Anesthesiologists (ASA) III and above
  • Body mass index (BMI) ≥ 40 kg/m2
  • Increased risk of developing peripartum haemorrhage
  • History of peripartum haemorrhage
  • Placenta previa major, accrete, increta, percreta
  • Gravida ≥ 5
  • Presence of large uterine fibroids
  • Congenital bleeding disorders such as Haemophilia A, Haemophilia B and Von Willebrand disease
  • Acquired bleeding disorders such as thrombocytopenia and coagulopathy
  • Contraindications to finger cuff orNIBP application, such as finger ischaemia, upper limb neurological deficit, discoloured nail
  • Cardiac arrhythmias and aortic regurgitation
  • Patient's refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Canselor Tuanku Muhriz

Cheras, Kuala Lumpur, 56000, Malaysia

RECRUITING

Related Publications (4)

  • Murabito P, Astuto M, Sanfilippo F, La Via L, Vasile F, Basile F, Cappellani A, Longhitano L, Distefano A, Li Volti G. Proactive Management of Intraoperative Hypotension Reduces Biomarkers of Organ Injury and Oxidative Stress during Elective Non-Cardiac Surgery: A Pilot Randomized Controlled Trial. J Clin Med. 2022 Jan 13;11(2):392. doi: 10.3390/jcm11020392.

    PMID: 35054083BACKGROUND
  • Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015 Sep;123(3):515-23. doi: 10.1097/ALN.0000000000000765.

    PMID: 26181335BACKGROUND
  • Frassanito L, Sonnino C, Piersanti A, Zanfini BA, Catarci S, Giuri PP, Scorzoni M, Gonnella GL, Antonelli M, Draisci G. Performance of the Hypotension Prediction Index With Noninvasive Arterial Pressure Waveforms in Awake Cesarean Delivery Patients Under Spinal Anesthesia. Anesth Analg. 2022 Mar 1;134(3):633-643. doi: 10.1213/ANE.0000000000005754.

    PMID: 34591796BACKGROUND
  • Andrzejewska A, Miegon J, Zacha S, Skonieczna-Zydecka K, Jarosz K, Zacha W, Biernawska J. The Impact of Intraoperative Haemodynamic Monitoring, Prediction of Hypotension and Goal-Directed Therapy on the Outcomes of Patients Treated with Posterior Fusion Due to Adolescent Idiopathic Scoliosis. J Clin Med. 2023 Jul 9;12(14):4571. doi: 10.3390/jcm12144571.

    PMID: 37510686BACKGROUND

MeSH Terms

Conditions

Hypotension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Azlina Masdar

    National University of Malaysia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Syarifah Noor Nazihah Sayed Masri

CONTACT

Nadhirah Abdul Halim

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
By computer randomisation, patients will be randomised into two groups, Group A (Intervention: HPI) or Group B (control: oNIBP). Standard monitoring will be applied, including a 3-lead electrocardiogram, pulse oximetry, and oNIBP in the upper arm. The oNIBP monitoring will be performed every 1 minute before, and every 3 minutes after the baby is delivered, up to 90 minutes of surgery duration. After 90 minutes, data collection will cease. In addition to the standard monitoring, all patients will have an Acumen IQ cuff placed on one of their fingers, as Appendix A shows, connected to haemodynamic monitoring using HemoSphere (Edwards Lifesciences) with HPI software enabled. In Group A, the Acumen IQ cuff, with HPI and other haemodynamics parameters, is available to the anaesthetist to view and act upon. While in Group B, the attending anaesthetist will be blinded from the HPI parameters.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A prospective, double-blinded, randomised controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2025

First Posted

March 25, 2025

Study Start

January 1, 2025

Primary Completion

October 31, 2025

Study Completion

January 31, 2026

Last Updated

May 23, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The data of the study will be available in public data repository

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After completion of the study and analysis for 5 years
Access Criteria
With permission from corresponding author

Locations